Latest Ratios: P/E Ratio 27.1x · EV/EBITDA 18.9x · ROE 4.8%. (2010–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $932M | $928M | $911M | $841M | $712M | $728M | — | — | — | — | — |
| Enterprise Value | $1.8B | $1.8B | $1.8B | $1.7B | $1.4B | $1.3B | — | — | — | — | — |
| P/E Ratio → | 27.06 | 26.94 | 12.35 | 10.04 | 46.12 | 8.69 | — | — | — | — | — |
| P/S Ratio | 5.96 | 5.94 | 4.61 | 4.57 | 6.10 | 7.74 | — | — | — | — | — |
| P/B Ratio | 1.32 | 1.31 | 1.23 | 1.13 | 1.16 | 1.12 | — | — | — | — | — |
| P/FCF | 19.92 | 19.84 | 11.00 | 13.60 | 12.20 | 25.57 | — | — | — | — | — |
| P/OCF | 19.92 | 19.84 | 11.00 | 13.60 | 12.20 | 25.57 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 11.33 | 9.00 | 9.11 | 11.65 | 14.35 | — | — | — | — | — |
| EV / EBITDA | 18.95 | 18.91 | — | — | — | — | — | — | — | — | — |
| EV / EBIT | 14.91 | 18.91 | 11.58 | 11.77 | 14.82 | 19.36 | — | — | — | — | — |
| EV / FCF | — | 37.85 | 21.47 | 27.14 | 23.30 | 47.40 | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.0% | 78.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 88.0% | 80.2% | 83.8% |
| Operating Margin | 76.1% | 76.1% | 77.7% | 77.4% | 78.6% | 74.1% | 85.5% | 84.5% | 80.1% | 69.4% | 66.2% |
| Net Profit Margin | 22.1% | 22.1% | 37.3% | 45.5% | 13.3% | 89.0% | 70.9% | 54.8% | 25.4% | 42.4% | 85.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.8% | 4.8% | 9.9% | 12.4% | 2.5% | 13.8% | 11.3% | 5.1% | 1.8% | 6.2% | 11.4% |
| ROA | 2.1% | 2.1% | 4.5% | 5.7% | 1.2% | 7.1% | 6.1% | 4.7% | 2.0% | 3.3% | 6.4% |
| ROIC | 5.6% | 5.6% | 7.2% | 7.5% | 5.4% | 4.5% | 5.6% | 4.6% | 3.7% | 4.2% | 3.9% |
| ROCE | 7.3% | 7.3% | 9.6% | 10.0% | 7.2% | 6.0% | 7.5% | 7.3% | 6.3% | 5.6% | 5.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.24 | 1.24 | 1.18 | 1.14 | 1.07 | 0.97 | 0.84 | 0.79 | 0.00 | 0.87 | 0.73 |
| Debt / EBITDA | 9.33 | 9.33 | — | — | — | — | — | 999999.00 | 0.00 | 6.65 | 11.09 |
| Net Debt / Equity | — | 1.19 | 1.17 | 1.13 | 1.06 | 0.95 | 0.84 | 0.78 | 0.32 | 0.82 | 0.69 |
| Net Debt / EBITDA | 9.00 | 9.00 | — | — | — | — | — | 317434000.00 | 5.48 | 6.24 | 10.49 |
| Debt / FCF | — | 18.01 | 10.46 | 13.54 | 11.10 | 21.82 | 14.87 | 10.75 | 13.69 | 12.10 | — |
| Interest Coverage | 1.63 | 1.63 | 2.50 | — | — | — | 4.26 | 3.38 | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | — | — | 1.44 | 1.11 | 1.01 | 1.44 | 0.95 | 0.99 | 19.49 | 1.80 | 1.99 |
| Quick Ratio | — | — | 1.44 | 1.11 | 1.01 | 1.44 | 0.95 | 0.99 | 19.49 | 1.80 | 1.99 |
| Cash Ratio | — | — | 0.26 | 0.20 | 0.18 | 0.31 | 0.09 | 0.26 | 6.99 | 1.56 | 1.33 |
| Asset Turnover | — | 0.10 | 0.12 | 0.11 | 0.09 | 0.07 | 0.07 | 0.07 | 0.06 | 0.07 | 0.06 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 7.3% | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 83.8% | 162.0% | 88.8% | 45.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.7% | 3.7% | 8.1% | 10.0% | 2.2% | 11.5% | — | — | — | — | — |
| FCF Yield | 5.0% | 5.0% | 9.1% | 7.4% | 8.2% | 3.9% | — | — | — | — | — |
| Buyback Yield | 0.1% | — | — | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 7.4% | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $37M | $37M | $36M | $31M | $28M | $28M | $17M | $11M | $8M | $5M |
Portfolio yield compression risk
Based on current market data, FCRX trades at a P/B of 1.32, which appears elevated compared to peers like GBDC and CGBD, despite the firm's reported -20.86% revenue growth and a P/E of 27.06 that suggests investors are pricing in recovery expectations not yet supported by fundamentals.
The current valuation multiples suggest a disconnect between market pricing and the underlying contraction of the loan portfolio. Investors should monitor whether this premium is a result of legacy brand perception or an expectation of future NAV accretion that remains unproven in the current interest rate environment.
As reported in recent financial statements, FCRX's ROIC has stagnated between 1.5% and 2.3% over the last ten quarters, significantly trailing the performance of industry peers and indicating that the firm is struggling to generate meaningful economic returns on its deployed capital base.
The persistent low ROIC suggests that the firm's investment strategy may be hampered by either high cost-of-capital or an inability to source high-yielding assets that justify the management fee structure. This trend warrants further investigation into whether the current portfolio composition is structurally incapable of delivering superior risk-adjusted returns.
According to quarterly filings, FCRX maintains a debt-to-equity ratio of 1.24, which is notably lower than several direct competitors, suggesting that management is prioritizing balance sheet preservation over aggressive growth, even as the firm faces a challenging environment for new loan originations and portfolio turnover.
While the low leverage provides a safety buffer, it also limits the potential for ROE expansion in a rising rate environment. The current interest coverage ratio of 1.65 indicates that debt service remains manageable, but investors should monitor if this conservatism is a strategic choice or a symptom of limited deal flow.
Based on reported figures, FCRX's asset turnover remains consistently low at 0.03, reflecting the inherent nature of a BDC model where capital is deployed into long-term debt instruments rather than high-velocity inventory, yet the erratic DSO trends suggest potential friction in the timing of interest and principal collections.
The lack of meaningful improvement in asset turnover suggests that the firm is not effectively recycling capital into higher-yielding opportunities. This inefficiency may be contributing to the observed revenue contraction, as the firm appears to be holding onto legacy assets rather than actively rotating into more attractive market segments.
The P/E ratio is frequently misapplied to FCRX, as it fails to account for the non-cash valuation adjustments inherent in Level 3 assets, which can artificially inflate or deflate earnings without reflecting the actual cash-generating capacity of the underlying loan portfolio.
Investors should instead focus on Price-to-NAV and Net Investment Income (NII) to better gauge the true economic value of the firm. Relying on P/E in this context obscures the volatility of unrealized gains and losses, which are often the primary drivers of reported net income fluctuations.
Includes 30+ ratios · 16 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FCRX stock.
Crescent Capital BDC, Inc.'s current P/E ratio is 27.1x. The historical average is 20.8x. This places it at the 80th percentile of its historical range.
Crescent Capital BDC, Inc.'s current EV/EBITDA is 18.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 18.9x.
Crescent Capital BDC, Inc.'s return on equity (ROE) is 4.8%. The historical average is 7.1%.
Based on historical data, Crescent Capital BDC, Inc. is trading at a P/E of 27.1x. This is at the 80th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Crescent Capital BDC, Inc.'s current dividend yield is 7.27%.
Crescent Capital BDC, Inc. has 78.0% gross margin and 76.1% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Crescent Capital BDC, Inc.'s Debt/EBITDA ratio is 9.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.